title: What cost weight loss?
authors.affiliation: Department of Medicine, Division of Cardiology, University of Colorado School of Medicine and, CPC Clinical Research, Aurora, CO 80045, USA. Will.Hiatt@UCDenver.edu
authors.forename: William R
authors.initials: WR
authors.lastname: Hiatt
authors.forename: Abraham
authors.initials: A
authors.lastname: Thomas
authors.forename: Allison B
authors.initials: AB
authors.lastname: Goldfine
mesh_terms: D019440:Anti-Obesity Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects; D016642:Bupropion / Q000008:administration & dosage / Q000009:adverse effects; D003503:Cyclobutanes / Q000008:administration & dosage / Q000009:adverse effects; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D009271:Naltrexone / Q000008:administration & dosage / Q000009:adverse effects; D009765:Obesity / Q000188:drug therapy* / Q000453:epidemiology; D010645:Phentermine / Q000008:administration & dosage / Q000009:adverse effects; D018570:Risk Assessment; D012307:Risk Factors; D000077236:Topiramate; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D019440:Anti-Obesity Agents; D001552:Benzazepines; D003503:Cyclobutanes; D016642:Bupropion; D000077236:Topiramate; D005632:Fructose; D009271:Naltrexone; C506658:lorcaserin; D010645:Phentermine; C058254:sibutramine